Ekso Bionics Holdings, Inc. (EKSO)

Market Cap	21.13M
Revenue (ttm)	18.28M
Net Income (ttm)	-15.20M
Shares Out	17.90M
EPS (ttm)	-1.10
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,868
Open	1.160
Previous Close	1.160
Day's Range	1.160 - 1.220
52-Week Range	0.620 - 3.129
Beta	1.64
Analysts	Strong Buy
Price Target	9.25 (+683.9%)
Earnings Date	Apr 29, 2024

About EKSO

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The com...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2005
• Employees: 70
• Stock Exchange: NASDAQ
• Ticker Symbol: EKSO

Financial Performance

In 2023, EKSO's revenue was $18.28 million, an increase of 41.57% compared to the previous year's $12.91 million. Losses were -$15.20 million, 0.78% more than in 2022.

Analyst Forecast

According to one analyst, the rating for EKSO stock is "Strong Buy" and the 12-month stock price forecast is $9.25.

Price Target

$9.25

(683.90% upside)

Analyst Consensus: Strong Buy